Fischer Medical to appoint new independent directors, reports Q2 financial results

Fischer Medical Ventures Limited will conduct a postal ballot from October 31, 2025 to November 30, 2025 for the appointment of two independent directors: Mr. Chan Sing En and Tan Sri Dato' Dr. Syed Jalaludin. The cut-off date for shareholders to be eligible for voting is October 24, 2025. Both appointments are for a first term of five consecutive years, effective October 28, 2025 for Mr. Chan Sing En, subject to shareholder approval.

In a board meeting on October 28, 2025, the company also approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. Standalone profit for the period was INR 83.77 lakhs, with total revenue from operations at INR 742.69 lakhs. Consolidated profit for the period was INR 1,389.58 lakhs, with total revenue from operations at INR 8,630.53 lakhs.

The board also appointed M/s. Nuren Lodaya & Associates as scrutinizer for the postal ballot process.